| 0.6 |
1.7 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.5 |
1.6 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.4 |
1.5 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.3 |
1.6 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.3 |
0.9 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.3 |
1.4 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.3 |
0.9 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.3 |
0.8 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.3 |
2.6 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.2 |
1.2 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.2 |
1.7 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 |
0.8 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 |
0.6 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.2 |
1.0 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
0.6 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.2 |
0.9 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 |
0.8 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.6 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.1 |
1.0 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.3 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
0.3 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.1 |
0.8 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 |
0.3 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.1 |
0.4 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.1 |
0.3 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.1 |
1.0 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 |
0.4 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 |
0.3 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.1 |
0.6 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.1 |
0.3 |
GO:0097168 |
condensed mesenchymal cell proliferation(GO:0072137) mesenchymal stem cell proliferation(GO:0097168) |
| 0.1 |
0.3 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
0.3 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.1 |
0.7 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.1 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.1 |
0.1 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.1 |
0.2 |
GO:0015920 |
regulation of phosphatidylcholine catabolic process(GO:0010899) lipopolysaccharide transport(GO:0015920) |
| 0.1 |
0.4 |
GO:0002317 |
plasma cell differentiation(GO:0002317) negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.2 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.1 |
0.2 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.1 |
0.2 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.1 |
0.4 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.2 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.0 |
0.3 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 0.0 |
0.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.4 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
1.2 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.0 |
0.3 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.0 |
0.5 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.3 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.9 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 |
1.0 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.0 |
0.3 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.6 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 |
0.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 |
0.4 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.0 |
0.1 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.0 |
1.6 |
GO:0048747 |
muscle fiber development(GO:0048747) |
| 0.0 |
0.1 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.0 |
0.2 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.4 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.0 |
0.4 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.5 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.8 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.1 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.0 |
0.1 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 |
0.5 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.0 |
0.4 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.0 |
0.1 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.0 |
0.2 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.2 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.0 |
0.1 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 0.0 |
0.1 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.1 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:0097343 |
positive regulation of oocyte development(GO:0060282) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.0 |
0.3 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
0.1 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 |
0.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.3 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
1.5 |
GO:0007369 |
gastrulation(GO:0007369) |
| 0.0 |
0.4 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.2 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
